Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Oct;88(5):326-328.
doi: 10.1016/j.rhum.2021.03.007. Epub 2021 Apr 2.

Le SARS-CoV-2 peut-il induire une arthrite réactionnelle ?

[Article in French]
Daniel Wendling  1   2 , Frank Verhoeven  1   3 , Mickael Chouk  1 , Clément Prati  1   3
Affiliations
Editorial

Le SARS-CoV-2 peut-il induire une arthrite réactionnelle ?

[Article in French]
Daniel Wendling et al. Rev Rhum Ed Fr. 2021 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • Can SARS-CoV-2 trigger reactive arthritis?
    Wendling D, Verhoeven F, Chouk M, Prati C. Wendling D, et al. Joint Bone Spine. 2021 Jan;88(1):105086. doi: 10.1016/j.jbspin.2020.105086. Epub 2020 Oct 27. Joint Bone Spine. 2021. PMID: 33127461 Free PMC article. No abstract available.

References

    1. Richez C., Flipo R.M., Berenbaum F. Managing patients with rheumatic diseases during the COVID-19 pandemic: the French Society of Rheumatology answers to most frequently asked questions up to May 2020. Joint Bone Spine. 2020 doi: 10.1016/j.jbspin.2020.05.006. - DOI - PMC - PubMed
    1. Landewé R.B., Machado P.M., Kroon F. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020;79:851–858. - PubMed
    1. Mikuls T.R., Johnson S.R., Fraenkel L. American College of Rheumatology Guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 2. Arthritis Rheumatol. 2020 doi: 10.1002/art.41437. [Online ahead of print] - DOI - PubMed
    1. Felten R., Chatelus E., Arnaud L. How and why are rheumatologists relevant to COVID-19? Joint Bone Spine. 2020;87:279–280. - PMC - PubMed
    1. Benucci M., Damiani A., Infantino M. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020;87:195–197. - PMC - PubMed

LinkOut - more resources